Intra-Cellular Therapies Inc (23I.MU)
| Previous close | 63.00 |
| Open | 61.00 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 61.00 - 61.00 |
| 52-week range | 44.00 - 72.00 |
| Volume | |
| Avg. volume | 7 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Intra-Cellular Therapies, Inc. ( NASDAQ:ITCI ) investors will be delighted, with the company turning in some strong...
Insider MonkeyIntra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q1 2024 Earnings Call Transcript
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q1 2024 Earnings Call Transcript May 7, 2024 Intra-Cellular Therapies, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and gentlemen, and welcome to Intra-Cellular Therapies’ First Quarter 2024 Earnings Conference Call. At […]
GlobeNewswireIntra-Cellular Therapies to Participate in Two Upcoming Investor Conferences
NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will participate in two upcoming investor conferences: 2024 RBC Capital Markets Global Healthcare ConferenceTuesday, May 14, 2024 at 10:00 a.m. ET in New York, NY Bank of America Healthcare Conference 2024Thursday, May 16, 2024 at 9:20 a.m. PT (12:2
